Coronary erosion following ST-elevated vasospastic coronary obstruction observed by coronary angioscopy

Int J Cardiovasc Imaging. 2020 Jul;36(7):1191-1192. doi: 10.1007/s10554-020-01817-5. Epub 2020 Mar 18.

Authors

Daisuke Kitano¹, Shunichi Yoda², Daisuke Fukamachi², Yasuo Okumura²

Affiliations

¹ Division of Cardiology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. kitano.daisuke@nihon-u.ac.jp.
² Division of Cardiology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.

PMID: 32189160
DOI: 10.1007/s10554-020-01817-5

No abstract available

Publication types

Case Reports
Video-Audio Media

MeSH terms

Acute Coronary Syndrome / diagnosis*
Acute Coronary Syndrome / etiology
Acute Coronary Syndrome / physiopathology
Acute Coronary Syndrome / therapy
Angioscopy*
Calcium Channel Blockers / therapeutic use
Coronary Artery Disease / complications
Coronary Artery Disease / diagnosis*
Coronary Artery Disease / physiopathology
Coronary Artery Disease / therapy
Coronary Stenosis / diagnosis*
Coronary Stenosis / etiology
Coronary Stenosis / physiopathology
Coronary Stenosis / therapy
Coronary Vasospasm / complications
Coronary Vasospasm / diagnosis*
Coronary Vasospasm / physiopathology
Coronary Vasospasm / therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Male
Middle Aged
Percutaneous Coronary Intervention / instrumentation
Plaque, Atherosclerotic
Predictive Value of Tests
Rupture, Spontaneous
ST Elevation Myocardial Infarction / diagnosis*
ST Elevation Myocardial Infarction / etiology
ST Elevation Myocardial Infarction / physiopathology
ST Elevation Myocardial Infarction / therapy
Stents
Treatment Outcome
Vasodilator Agents / therapeutic use

Substances

Calcium Channel Blockers
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Vasodilator Agents